JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Clinical trial NCT06973564 · RECRUITING
Trial details
- NCT number
- NCT06973564
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-29
- Primary completion
- 2027-11-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.